Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Collagen Solutions Plc (COS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011349
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company offers sourcing and supply of high grade collagen; provision of functional collagen bio-materials; and contract manufacture of collagen-based products and medical devices. It provides bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications including bone, cartilage and tendon, and veins and blood vessels. Collagen Solutions’ products are used in research, diagnostics, medical devices and regenerative medicine. The company offers product development and contract manufacturing services including technology transfer and regulatory support to pharmaceutical and medical device companies. It has operations in the UK, the US, South Korea and New Zealand. Collagen Solutions is headquartered in Glasgow, the UK.

Collagen Solutions Plc (COS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Collagen Solutions Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Collagen Solutions Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Collagen Solutions Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Collagen Solutions Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Collagen Solutions Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Collagen Solutions Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
Collagen Solutions Acquires ChondroMimetic from Orthomimetics and Cambridge Enterprise 11
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 13
Venture Financing 14
Collbio Raises US$0.4 Million In Venture Financing 14
Partnerships 15
Collagen Solutions Enters into Development Agreement with Smart Matrix 15
Collagen Solutions Enters into Agreement with Electrospinning 16
Collagen Solutions Enters into Agreement with Kyeron Medical Innovations 17
Collagen Solutions Enters into Research Agreement with Jellagen 18
UCL Business Enters into Licensing Agreement with Collagen Solutions 19
Equity Offering 20
Collagen Solutions to Raise USD7.6 million in Private Placement of Shares 20
Collagen Solutions to Raise USD2.3 million in Rights Offering of Shares 22
Collagen Solutions Raises USD9.4 Million in Private Placement of Shares 24
Collagen Solutions Raises USD6 Million in Private Placement of Shares 25
Debt Offering 26
Collagen Solutions Raises USD2.5 Million in Private Placement of Bonds 26
Collagen Solutions to Raise USD1.3 Million in Private Placement of Bonds 27
Collagen Solutions to Raise USD1.25 Million in Private Placement of Bonds 28
Asset Transactions 29
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 29
Acquisition 30
Collagen Solutions Acquires Southern Lights Biomaterials for USD9.4 Million 30
Healthcare Investment Acquires Collbio in Reverse Takeover Transaction 31
Collbio Acquires Angel Biomedical, Maker Of Biomedical Collagen Products, From Angel Biotechnology 32
Collagen Solutions Plc – Key Competitors 33
Collagen Solutions Plc – Key Employees 34
Collagen Solutions Plc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Dec 05, 2017: Collagen Solutions: Interim Results for the six months ended 30 September 2017 36
Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 37
Dec 19, 2016: Collagen Solutions Announces Interim Results for the six months ended 30 September 2016 38
Jul 11, 2016: Collagen Solutions Announces Final Results for the year ended 31 March 2016 39
May 03, 2016: Collagen Solutions Announces Preliminary FY 2016 Revenue 44
Corporate Communications 45
Dec 18, 2017: Collagen Solutions Strengthens Board with Non-Executive Appointment 45
Dec 14, 2017: Collagen Solutions: Appointment of Chief Financial Officer 46
Jan 19, 2017: Collagen Solutions Team Strengthened with New Scientific Advisory Board Appointments 47
May 04, 2016: Collagen Solutions Appoints Jamal Rushdy as Chief Executive Officer 48
May 03, 2016: Collagen Solutions Announces Leadership Changes 49
Product News 50
Jun 13, 2017: Collagen Solutions announces Provisional patent for Bone Graft Substitute formulation submitted 50
Other Significant Developments 51
Oct 26, 2017: Collagen Solutions: Trading Update and Notice of Results 51
Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 52
Apr 24, 2017: Collagen Solutions: Consolidation of US R&D activities and Board change 58
Mar 20, 2017: Collagen Solutions introduces new online sales initiative in the US 59
Apr 19, 2016: Collagen Solutions Supplies Collagen Materials to Merck 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Collagen Solutions Plc, Medical Equipment, Key Facts, 2017 2
Collagen Solutions Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Collagen Solutions Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Collagen Solutions Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Collagen Solutions Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Collagen Solutions Plc, Deals By Market, 2011 to YTD 2017 9
Collagen Solutions Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Collagen Solutions Acquires ChondroMimetic from Orthomimetics and Cambridge Enterprise 11
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 13
Collbio Raises US$0.4 Million In Venture Financing 14
Collagen Solutions Enters into Development Agreement with Smart Matrix 15
Collagen Solutions Enters into Agreement with Electrospinning 16
Collagen Solutions Enters into Agreement with Kyeron Medical Innovations 17
Collagen Solutions Enters into Research Agreement with Jellagen 18
UCL Business Enters into Licensing Agreement with Collagen Solutions 19
Collagen Solutions to Raise USD7.6 million in Private Placement of Shares 20
Collagen Solutions to Raise USD2.3 million in Rights Offering of Shares 22
Collagen Solutions Raises USD9.4 Million in Private Placement of Shares 24
Collagen Solutions Raises USD6 Million in Private Placement of Shares 25
Collagen Solutions Raises USD2.5 Million in Private Placement of Bonds 26
Collagen Solutions to Raise USD1.3 Million in Private Placement of Bonds 27
Collagen Solutions to Raise USD1.25 Million in Private Placement of Bonds 28
Collagen Solutions (UK) Acquires Assets of Collagen Solutions 29
Collagen Solutions Acquires Southern Lights Biomaterials for USD9.4 Million 30
Healthcare Investment Acquires Collbio in Reverse Takeover Transaction 31
Collbio Acquires Angel Biomedical, Maker Of Biomedical Collagen Products, From Angel Biotechnology 32
Collagen Solutions Plc, Key Competitors 33
Collagen Solutions Plc, Key Employees 34
Collagen Solutions Plc, Other Locations 35
Collagen Solutions Plc, Subsidiaries 35

★海外企業調査レポート[Collagen Solutions Plc (COS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guangdong Electric Power Development Co Ltd (000539):電力:M&Aディール及び事業提携情報
    Summary Guangdong Electric Power Development Co., Ltd. (Guangdong Electric) is a leading china based electricity distribution company. The company is a subsidiary of Guangdong Yudean Group Co., Ltd. Guangdong Electric is engaged in developing electric power plants in the country. The company is also …
  • MallInckrodt Plc (MNK)-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt Plc (Mallinckrodt) is a healthcare products provider that offers generics and active pharmaceutical ingredients. The company offers generic products which include addiction treatment products, compounding powders, unit dose products and resource tool kits. Its active pharmaceuti …
  • Nippon Steel & Sumitomo Metal Corporation:企業のM&A・事業提携・投資動向
    Nippon Steel & Sumitomo Metal Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nippon Steel & Sumitomo Metal Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Cleco Corporate Holdings LLC:企業の戦略的SWOT分析
    Cleco Corporate Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Inventec Corporation (2356):企業の財務・戦略的SWOT分析
    Inventec Corporation (2356) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Nissin Foods Holdings Co Ltd.:企業の戦略・SWOT・財務分析
    Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • Synedgen Inc-医療機器分野:企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • Genzyme Corp-医療機器分野:企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Larsen & Toubro Limited:企業の戦略・SWOT・財務分析
    Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report Summary Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SARIA AS GmbH & Co KG:企業の戦略的SWOT分析
    SARIA AS GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kellogg Co:企業の戦略・SWOT・財務情報
    Kellogg Co - Strategy, SWOT and Corporate Finance Report Summary Kellogg Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kawasaki Kisen Kaisha Ltd (9107):石油・ガス:M&Aディール及び事業提携情報
    Summary Kawasaki Kisen Kaisha Ltd (K Line) is a global logistics company. It provides land transportation, air transportation, marine transportation, and harbor transportation. It owns and operates dry bulk carriers, LNG carriers, tankers, car carriers and containerships. The company also provides s …
  • Qurain Petrochemical Industries Co (ALQURAIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Qurain Petrochemical Industries Co (QPIC), a subsidiary of Kuwait Projects Company Holding KSC is an investment holding company that invests in petrochemical industry and related sectors. The company develops business and financial solutions. It provides investment portfolio such as EQUATE, …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …
  • Recylex SA:企業の戦略・SWOT・財務分析
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sosei Group Corp (4565):製薬・医療:M&Aディール及び事業提携情報
    Summary Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆